Tendyne Holdings, Inc, headquartered in Roseville, MN, is a private medical device company developing a unique Transcatheter Mitral Valve Implant (TMVI). Implanted in a beating heart in a hybrid operating room, the Tendyne design has proprietary and patented features that can treat a variety of mitral pathologies. With a less invasive approach than open cardiac surgery, TMVI may result in similar outcomes with fewer surgical complications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/10/14 | $25,000,000 | Series C |
Apple Tree Partners Boulle Group | undisclosed |
